Skip to content

Retrospective Observational Registry of Patients With Atrial Fibrillation From Vigo´s Health Area

Retrospective Observational Registry of Patients With Atrial Fibrillation From Vigo´s Health Area (Registro Observacional Retrospectivo de Pacientes Con Fibrilación Auricular Del Área de Vigo)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04364516
Acronym
CardioCHUVI-AF
Enrollment
15000
Registered
2020-04-28
Start date
2018-11-26
Completion date
2023-11-26
Last updated
2020-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Keywords

Atrial Fibrllation; Anticoagulation; Bleeding; Embolism.

Brief summary

Registry of all consecutive patients with atrial fibrillation from Heath Area of Vigo, since 2013 to 2020, in order to study therapy, mortality, cardiovascular complications and bleeding events.

Detailed description

Retrospective observational registry of patients diagnosed of atrial fibrillation between 2013 and 2020. Clinical, analytical and echocardiographic data will be recorded, as well as therapeutic prescription information. Data on mortality and cardioembolic and hemorrhagic events will be collected during follow-up. The aim is to study the prevalence and incidence of atrial fibrillation, the anticoagulant treatment according to cardioembolic risk, the thromboembolic events and hemorrhagic events, the risk of mortality (Cardiovascular, Non-Cardiovascular), the contemporary management (Rhythm control versus frequency control strategy), and other complications, such as heart failure, acute coronary syndrome or cancer.

Interventions

DRUGAnticoagulation

Study of prognostic impact according to oral anticoagulation therapy (Vitamin K Antagonists or Direct Oral Anticoagulants)

Sponsors

Hospital Álvaro Cunqueiro
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* All patients with confirmed diagnoses of atrial fibrillation by ECG.

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
MortalityFollow-up (3 years)All cause Mortality

Secondary

MeasureTime frameDescription
BleedingFollow-up (3 years)Bleeding according to International Society on Thrombosis and Haemostasis(ISTH) classiffication
EmbolismFollow-up (3 years)Embolic events include ischemic stroke, transient ischemic attack (TIA), pulmonary embolism (PE), and systemic embolism (SE). Ischemic stroke was defined as sudden onset of a focal deficit consistent with occlusion of a major cerebral artery (documented by means of magnet resonance imaging \[MRI \]or computer tomography \[CT\]) and categorized. TIA was defined as a temporary neurologic deficit presumably due to reduced blood flow in a particular cerebral artery lasting for ≤24 hours with complete resolution of the neurologic deficit. A PE event was confirmed by spiral CT, perfusion-ventilation scan, pulmonary angiography, or autopsy) and resulted in a final PE diagnosis. A SE event was defined as any end-organ ischemia other than in the brain, heart, eyes, and lungs, caused by abrupt vascular insufficiency associated with clinical or radiological evidence of arterial occlusion in the absence of another likely mechanism.

Countries

Spain

Contacts

Primary ContactSONIA BLANCO PRIETO, PhD
raposeiras26@hotmail.com620170387

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026